CAS: 5623-18-7 - Metfol-B
Fórmula:C15H14N6O3
InChI:InChI=1S/C15H14N6O3/c1-21(10-4-2-8(3-5-10)14(23)24)7-9-6-17-12-11(18-9)13(22)20-15(16)19-12/h2-6H,7H2,1H3,(H,23,24)(H3,16,17,19,20,22)
Clave InChI:InChIKey=QHNLFEQJGRZKTK-UHFFFAOYSA-N
SMILES:O=C(O)C1=CC=C(C=C1)N(C)CC=2N=C3C(=O)N=C(N=C3NC2)N
- Sinónimos:
- 4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]benzoic acid
- Benzoic Acid, 4-[[(2-Amino-1,4-Dihydro-4-Oxo-6-Pteridinyl)Methyl]Methylamino]-
- Benzoic acid, 4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]-
- Benzoic acid, p-[[(2-amino-4-hydroxy-6-pteridinyl)methyl]methylamino]-
- Metfol-B
- NSC 408937
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Methotrexate EP Impurity D REF: 4Z-M-705CAS: 5623-18-7 | - - - | A consultar | Mar 17 Dic 24 |
 | N10-Methyl Pteroic Acid REF: TR-M326265CAS: 5623-18-7 | - - - | 214,00 €~623,00 € | Vie 20 Dic 24 |
 | N10-Methyl pteroic acid REF: 3D-FM25554CAS: 5623-18-7 | Min. 95% | A consultar | Mar 21 Ene 25 |
Ref: 4Z-M-705
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
N10-Methyl Pteroic Acid
CAS:5623-18-7
Impurity Methotrexate EP Impurity D Applications N10-Methyl Pteroic Acid (Methotrexate EP Impurity D) is a …
Fórmula:
C15H14N6O3
Forma y color:
Orange To Dark Red
Peso molecular:
326.31
Ref: TR-M326265
| 25mg | 214,00 € | ||
| 50mg | 351,00 € | ||
| 100mg | 623,00 € |
Entrega estimada en Estados Unidos, el Viernes 20 de Diciembre de 2024
N10-Methyl pteroic acid
CAS:5623-18-7
N10-Methyl pteroic acid is a novel immunosuppressant that inhibits T-cell proliferation and promotes regression of …
Fórmula:
C15H14N6O3
Pureza:
Min. 95%
Peso molecular:
326.31 g/mol
Ref: 3D-FM25554
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
